Vitamin C renal leak as a clinical diagnostic tool in the detection, monitoring, and management of acute and chronic diseases
This technology includes a clinical diagnostic tool for measuring vitamin C elimination by human kidneys that can be used for detecting, monitoring, and managing acute and chronic diseases. Findings revealed significant associations between vitamin C renal leak status and clinical variables affecting renal function and blood glucose. The technology uses vitamin C depletion-repletion kinetics and pharmacokinetic models to establish a physiological vitamin C renal threshold.
Java Applet for Modeling Human Metabolism and Energy Expenditure for Adaptive Dieting and Exercise Regimens
Podocin Promoter, Reverse Tetracycline Transactivator Mice for Studying Podocyte Injury
Polyclonal Antibodies to Apolipoprotein L1 for Use in Basic Science Research
Monoclonal Antibodies to HIV-1 Vpr
Conditionally Immortalized Human Podocyte Cell Lines
Construct for Tetracycline Inducible Podocyte Specific Gene Expression in Mice
Thyclotide Peptide Conjugates With Cell Permeability And Inhibitory Activity
Thyclotides are oligomeric molecules with chiral tetrahydrofuran (THF) diamine units consisting of either R,R or
S,S stereochemistry. Thyclotide sequences with R,R stereochemistry bind to complementary DNA and RNA
sequences with strong affinity and sequence specificity, while thyclotides with S,S stereochemistry have a helical
handedness that does not allow binding to DNA or RNA. Thyclotides are cell permeable and can be used to
suppress microRNA activity in cells. Peptides are oligomeric molecules consisting of amino acids found in
Sidechain Functionalized S-Acylbenzamides With Anti-HIV Activity
HIV infection remains a major medical problem, with approximately 38 million people worldwide living with HIV. Nipamovir and SAMT-247 are simple and inexpensive small molecules that inactivate HIV virus by interference with final maturation steps of the virus. This mechanism provides a high barrier for HIV to develop resistance. In fact, lab experiments designed to encourage HIV to develop resistance to Nipamovir and SAMT-247 have all failed. In animal tests, Nipamovir and SAMT-247 do not display toxic side effects.